Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor

Details for Australian Patent Application No. 2007316558 (hide)

Owner Abbott GmbH & Co. KG

Inventors Liepold, Bernd; Nehen, Christian; Rosenberg, Jorg; Knobloch, Martin

Agent Watermark

Pub. Number AU-A-2007316558

PCT Pub. Number WO2008/055966

Priority 06023367.3 09.11.06 EP; 60/999,579 19.10.07 US

Filing date 8 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/055966 Priority application(s): WO2008/055966

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316562-Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol

2007316557-Melt-processed imatinib dosage form